Executive record

Robin C. Kramer

Robin C. Kramer signed Biogen's latest annual report, the 10-K filed February 6, 2026, as Executive Vice President and Chief Financial Officer (principal financial officer).

1 verified record · 1 company · current seat on the record: Biogen

Career line from the records

Each seat as a filing states it, newest first. Titles appear only as the filing prints them for this person.

2026-02-0610-K signatureBiogencurrent seat
Signed the annual report as Executive Vice President and Chief Financial Officer (principal financial officer)
10-K filed February 6, 2026 · sec.gov

Companies

BiogenBIIB

Biological Products, (No Diagnostic Substances)

This page lists only verified filing records that name Robin C. Kramer, matched by the name as the filings print it; it is not a career history. Corrections: the corrections page.